Homing immunotherapies

Why platelets could make good drug carriers for cancer immunotherapies

Chasing solid tumor resection with immunotherapy can prevent cancer recurrence by eliminating circulating tumor cells and microtumors, but the approach has low efficacy in some patients and runs the risk of systemic side effects. North Carolina researchers have found a way around these limitations by using platelets to target cancer immunotherapies to surgical wound

Read the full 546 word article

User Sign In